 Edward Jones
Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fires | 7 | 2023 | 88 | 3.060 |
Why?
| | Robotic Surgical Procedures | 4 | 2023 | 115 | 2.610 |
Why?
| | Operating Rooms | 7 | 2022 | 115 | 2.600 |
Why?
| | Laparoscopy | 7 | 2023 | 450 | 2.420 |
Why?
| | Electrosurgery | 8 | 2022 | 44 | 2.190 |
Why?
| | Telemedicine | 4 | 2023 | 792 | 1.810 |
Why?
| | Gastric Balloon | 2 | 2024 | 17 | 1.740 |
Why?
| | Hernia, Inguinal | 3 | 2023 | 35 | 1.740 |
Why?
| | Burns, Electric | 5 | 2017 | 26 | 1.730 |
Why?
| | Burns | 6 | 2023 | 288 | 1.620 |
Why?
| | Veterans | 4 | 2024 | 1375 | 1.510 |
Why?
| | Energy Transfer | 4 | 2020 | 49 | 1.420 |
Why?
| | Robotics | 2 | 2022 | 93 | 1.320 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2021 | 958 | 1.140 |
Why?
| | Surgeons | 3 | 2022 | 264 | 1.030 |
Why?
| | Enteral Nutrition | 3 | 2024 | 188 | 0.990 |
Why?
| | Natural Orifice Endoscopic Surgery | 2 | 2015 | 33 | 0.950 |
Why?
| | Esophageal Achalasia | 2 | 2015 | 28 | 0.940 |
Why?
| | Deglutition Disorders | 3 | 2022 | 134 | 0.880 |
Why?
| | Esophagoscopy | 2 | 2015 | 198 | 0.860 |
Why?
| | Glucagon-Like Peptides | 1 | 2024 | 50 | 0.860 |
Why?
| | Hyperthermia, Induced | 2 | 2021 | 109 | 0.850 |
Why?
| | Weight Loss | 3 | 2024 | 738 | 0.850 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2023 | 58 | 0.830 |
Why?
| | Intraoperative Complications | 4 | 2017 | 129 | 0.830 |
Why?
| | Pacemaker, Artificial | 3 | 2020 | 110 | 0.830 |
Why?
| | Gastrostomy | 2 | 2022 | 110 | 0.820 |
Why?
| | Patient Discharge | 3 | 2024 | 836 | 0.820 |
Why?
| | Postoperative Complications | 14 | 2024 | 2477 | 0.810 |
Why?
| | General Surgery | 1 | 2023 | 153 | 0.760 |
Why?
| | Swine | 10 | 2020 | 764 | 0.760 |
Why?
| | Obesity, Morbid | 2 | 2023 | 241 | 0.730 |
Why?
| | Defibrillators, Implantable | 3 | 2020 | 300 | 0.720 |
Why?
| | Catheter Ablation | 2 | 2017 | 336 | 0.710 |
Why?
| | Surgical Wound | 2 | 2020 | 21 | 0.710 |
Why?
| | 2-Propanol | 2 | 2019 | 22 | 0.700 |
Why?
| | Chlorhexidine | 2 | 2019 | 24 | 0.700 |
Why?
| | Oxygen | 4 | 2023 | 915 | 0.690 |
Why?
| | Retrospective Studies | 22 | 2024 | 14522 | 0.670 |
Why?
| | Electrocoagulation | 5 | 2019 | 38 | 0.640 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 18 | 0.630 |
Why?
| | Microwaves | 1 | 2019 | 37 | 0.630 |
Why?
| | Surgical Procedures, Operative | 5 | 2024 | 244 | 0.630 |
Why?
| | Endoscopy | 3 | 2020 | 288 | 0.620 |
Why?
| | Ethanol | 2 | 2023 | 591 | 0.620 |
Why?
| | Quality of Life | 5 | 2023 | 2688 | 0.610 |
Why?
| | Smoke | 1 | 2019 | 140 | 0.590 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 171 | 0.590 |
Why?
| | Humans | 53 | 2024 | 129626 | 0.580 |
Why?
| | Kidney Neoplasms | 1 | 2021 | 348 | 0.560 |
Why?
| | Skin | 2 | 2019 | 727 | 0.550 |
Why?
| | Colonic Neoplasms | 1 | 2019 | 242 | 0.540 |
Why?
| | Carbon Dioxide | 1 | 2019 | 259 | 0.540 |
Why?
| | Povidone-Iodine | 1 | 2017 | 12 | 0.540 |
Why?
| | Endoscopes | 1 | 2017 | 17 | 0.540 |
Why?
| | Medicare | 1 | 2022 | 708 | 0.540 |
Why?
| | Intubation, Gastrointestinal | 3 | 2024 | 76 | 0.530 |
Why?
| | Anti-Infective Agents, Local | 1 | 2017 | 42 | 0.530 |
Why?
| | Occupational Injuries | 1 | 2017 | 45 | 0.530 |
Why?
| | Cholecystectomy, Laparoscopic | 2 | 2015 | 51 | 0.520 |
Why?
| | Solvents | 1 | 2017 | 108 | 0.520 |
Why?
| | Abdominal Injuries | 2 | 2016 | 118 | 0.520 |
Why?
| | Preoperative Care | 2 | 2023 | 338 | 0.500 |
Why?
| | Electromagnetic Phenomena | 4 | 2020 | 22 | 0.500 |
Why?
| | Surgical Wound Infection | 2 | 2017 | 283 | 0.470 |
Why?
| | Follow-Up Studies | 8 | 2023 | 4894 | 0.470 |
Why?
| | Herniorrhaphy | 3 | 2023 | 57 | 0.470 |
Why?
| | Pelvic Exenteration | 1 | 2014 | 11 | 0.460 |
Why?
| | Wounds, Nonpenetrating | 2 | 2016 | 272 | 0.450 |
Why?
| | Liver Neoplasms | 1 | 2019 | 639 | 0.450 |
Why?
| | Internship and Residency | 1 | 2023 | 1050 | 0.440 |
Why?
| | Pelvis | 1 | 2014 | 104 | 0.430 |
Why?
| | Salvage Therapy | 1 | 2014 | 136 | 0.430 |
Why?
| | Sentinel Lymph Node Biopsy | 2 | 2013 | 108 | 0.420 |
Why?
| | Rectal Neoplasms | 1 | 2014 | 134 | 0.420 |
Why?
| | Multiple Trauma | 1 | 2014 | 101 | 0.420 |
Why?
| | Middle Aged | 24 | 2024 | 31136 | 0.410 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2012 | 9 | 0.410 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 232 | 0.400 |
Why?
| | Laparoscopes | 1 | 2012 | 10 | 0.390 |
Why?
| | Aged | 19 | 2024 | 22061 | 0.390 |
Why?
| | Hemostasis, Surgical | 1 | 2012 | 22 | 0.380 |
Why?
| | Heart Injuries | 1 | 2012 | 36 | 0.370 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2022 | 219 | 0.370 |
Why?
| | Trauma Centers | 1 | 2014 | 402 | 0.360 |
Why?
| | Wounds, Penetrating | 1 | 2012 | 63 | 0.360 |
Why?
| | Coronary Vessels | 1 | 2012 | 239 | 0.330 |
Why?
| | Prospective Studies | 9 | 2023 | 7135 | 0.330 |
Why?
| | Surgical Mesh | 2 | 2023 | 46 | 0.320 |
Why?
| | Female | 26 | 2024 | 68734 | 0.320 |
Why?
| | Male | 27 | 2024 | 63670 | 0.320 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2014 | 627 | 0.320 |
Why?
| | Melanoma | 2 | 2013 | 730 | 0.320 |
Why?
| | Animals | 14 | 2022 | 35391 | 0.310 |
Why?
| | Body Mass Index | 3 | 2024 | 2274 | 0.310 |
Why?
| | Skin Neoplasms | 2 | 2013 | 829 | 0.300 |
Why?
| | Cattle | 3 | 2022 | 977 | 0.300 |
Why?
| | Radio Waves | 4 | 2017 | 17 | 0.300 |
Why?
| | Adult | 17 | 2024 | 35599 | 0.300 |
Why?
| | Models, Animal | 3 | 2019 | 378 | 0.290 |
Why?
| | Patient Care Team | 2 | 2024 | 600 | 0.290 |
Why?
| | Patient Readmission | 4 | 2023 | 653 | 0.290 |
Why?
| | Prostatic Neoplasms | 1 | 2014 | 998 | 0.270 |
Why?
| | Elective Surgical Procedures | 2 | 2021 | 164 | 0.260 |
Why?
| | Heart Ventricles | 1 | 2012 | 781 | 0.260 |
Why?
| | Delirium | 2 | 2017 | 78 | 0.260 |
Why?
| | Cardiac Surgical Procedures | 1 | 2012 | 506 | 0.260 |
Why?
| | Proteins | 1 | 2012 | 944 | 0.250 |
Why?
| | Equipment Failure | 3 | 2015 | 106 | 0.240 |
Why?
| | United States Department of Veterans Affairs | 3 | 2024 | 623 | 0.230 |
Why?
| | Treatment Outcome | 8 | 2023 | 10219 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 2512 | 0.220 |
Why?
| | Walking | 3 | 2023 | 500 | 0.220 |
Why?
| | Pilot Projects | 3 | 2024 | 1592 | 0.220 |
Why?
| | Operative Time | 2 | 2015 | 124 | 0.220 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2024 | 92 | 0.220 |
Why?
| | Hernia | 1 | 2023 | 10 | 0.210 |
Why?
| | Geriatric Assessment | 2 | 2024 | 205 | 0.210 |
Why?
| | Hot Temperature | 3 | 2016 | 370 | 0.210 |
Why?
| | Carcinoma | 2 | 2016 | 214 | 0.210 |
Why?
| | United States | 8 | 2024 | 13871 | 0.200 |
Why?
| | Coronary Artery Bypass | 1 | 2024 | 224 | 0.190 |
Why?
| | Aged, 80 and over | 9 | 2024 | 7052 | 0.190 |
Why?
| | Cholecystectomy | 1 | 2022 | 59 | 0.190 |
Why?
| | Postoperative Care | 1 | 2023 | 241 | 0.190 |
Why?
| | Equipment Design | 3 | 2019 | 514 | 0.190 |
Why?
| | Hospitals | 2 | 2023 | 637 | 0.190 |
Why?
| | Nutritional Status | 1 | 2024 | 329 | 0.190 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 1914 | 0.190 |
Why?
| | Surgical Clearance | 1 | 2021 | 4 | 0.180 |
Why?
| | Abdomen | 1 | 2021 | 118 | 0.180 |
Why?
| | Weight Gain | 1 | 2024 | 509 | 0.170 |
Why?
| | Obesity | 2 | 2024 | 2882 | 0.170 |
Why?
| | Health Services for the Aged | 1 | 2021 | 71 | 0.170 |
Why?
| | Patient Participation | 1 | 2024 | 414 | 0.170 |
Why?
| | Air | 1 | 2020 | 36 | 0.170 |
Why?
| | Perioperative Care | 1 | 2021 | 151 | 0.170 |
Why?
| | Surgical Instruments | 3 | 2016 | 51 | 0.160 |
Why?
| | Colonoscopy | 1 | 2022 | 238 | 0.160 |
Why?
| | Immunocompetence | 1 | 2019 | 43 | 0.160 |
Why?
| | Aftercare | 1 | 2021 | 203 | 0.160 |
Why?
| | Hernia, Hiatal | 1 | 2019 | 32 | 0.160 |
Why?
| | Gas Scavengers | 1 | 2019 | 3 | 0.160 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 301 | 0.150 |
Why?
| | Wearable Electronic Devices | 1 | 2019 | 45 | 0.150 |
Why?
| | Liver | 2 | 2017 | 1842 | 0.150 |
Why?
| | Rural Population | 1 | 2022 | 516 | 0.150 |
Why?
| | Length of Stay | 2 | 2021 | 1122 | 0.150 |
Why?
| | Neoplasm Seeding | 1 | 2016 | 7 | 0.140 |
Why?
| | Decision Making | 1 | 2024 | 863 | 0.140 |
Why?
| | Temperature | 1 | 2020 | 637 | 0.140 |
Why?
| | Abdominal Wall | 1 | 2016 | 23 | 0.130 |
Why?
| | Abdominal Neoplasms | 1 | 2016 | 34 | 0.130 |
Why?
| | Inpatients | 1 | 2021 | 475 | 0.130 |
Why?
| | Administration, Cutaneous | 1 | 2017 | 124 | 0.130 |
Why?
| | Electric Impedance | 1 | 2017 | 102 | 0.130 |
Why?
| | Urogenital System | 1 | 2016 | 16 | 0.130 |
Why?
| | Long-Term Care | 1 | 2016 | 92 | 0.130 |
Why?
| | Urinalysis | 1 | 2016 | 75 | 0.130 |
Why?
| | Hand | 1 | 2017 | 157 | 0.120 |
Why?
| | Injury Severity Score | 2 | 2016 | 509 | 0.120 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 207 | 0.120 |
Why?
| | Postoperative Period | 3 | 2021 | 330 | 0.120 |
Why?
| | Esophageal pH Monitoring | 1 | 2015 | 23 | 0.120 |
Why?
| | Electrical Equipment and Supplies | 1 | 2015 | 8 | 0.120 |
Why?
| | Recovery of Function | 1 | 2019 | 642 | 0.120 |
Why?
| | Pneumoperitoneum | 1 | 2015 | 12 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2017 | 1087 | 0.120 |
Why?
| | Polypropylenes | 1 | 2014 | 14 | 0.120 |
Why?
| | Argon Plasma Coagulation | 1 | 2014 | 4 | 0.120 |
Why?
| | Time Factors | 3 | 2015 | 6555 | 0.120 |
Why?
| | Clinical Competence | 1 | 2022 | 1017 | 0.110 |
Why?
| | Alloys | 1 | 2014 | 34 | 0.110 |
Why?
| | Ultrasonics | 1 | 2014 | 49 | 0.110 |
Why?
| | Postoperative Hemorrhage | 1 | 2015 | 87 | 0.110 |
Why?
| | Gastrectomy | 1 | 2015 | 102 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1491 | 0.110 |
Why?
| | Hemostatics | 1 | 2014 | 50 | 0.110 |
Why?
| | Umbilicus | 1 | 2013 | 17 | 0.110 |
Why?
| | Ear, External | 1 | 2013 | 24 | 0.100 |
Why?
| | Mohs Surgery | 1 | 2013 | 25 | 0.100 |
Why?
| | Physicians | 1 | 2021 | 866 | 0.100 |
Why?
| | Jejunum | 1 | 2012 | 30 | 0.100 |
Why?
| | Hypocalcemia | 1 | 2012 | 28 | 0.100 |
Why?
| | Blood Coagulation | 1 | 2014 | 239 | 0.100 |
Why?
| | Physical Examination | 1 | 2014 | 234 | 0.100 |
Why?
| | Survival Rate | 2 | 2016 | 1872 | 0.100 |
Why?
| | Radiography, Abdominal | 1 | 2012 | 46 | 0.100 |
Why?
| | Stomach | 1 | 2012 | 109 | 0.100 |
Why?
| | Laparotomy | 1 | 2012 | 106 | 0.100 |
Why?
| | Thyroidectomy | 1 | 2012 | 89 | 0.100 |
Why?
| | Intensive Care Units | 1 | 2016 | 735 | 0.090 |
Why?
| | Risk Factors | 6 | 2024 | 9786 | 0.090 |
Why?
| | Head and Neck Neoplasms | 1 | 2016 | 544 | 0.090 |
Why?
| | Disease-Free Survival | 1 | 2013 | 646 | 0.090 |
Why?
| | Patient Satisfaction | 1 | 2015 | 633 | 0.090 |
Why?
| | Pancreatectomy | 1 | 2013 | 242 | 0.090 |
Why?
| | Vitamin D Deficiency | 1 | 2012 | 177 | 0.090 |
Why?
| | Electrodes | 3 | 2016 | 105 | 0.080 |
Why?
| | Preoperative Period | 2 | 2024 | 115 | 0.080 |
Why?
| | Young Adult | 5 | 2017 | 12455 | 0.080 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5455 | 0.080 |
Why?
| | Prognosis | 1 | 2014 | 3774 | 0.060 |
Why?
| | Incidence | 3 | 2017 | 2641 | 0.060 |
Why?
| | Tertiary Care Centers | 2 | 2017 | 148 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 2013 | 880 | 0.060 |
Why?
| | Hospitals, University | 2 | 2015 | 178 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1560 | 0.060 |
Why?
| | Adolescent | 4 | 2017 | 20412 | 0.060 |
Why?
| | Quality Improvement | 2 | 2021 | 1101 | 0.050 |
Why?
| | Mice | 1 | 2019 | 16961 | 0.050 |
Why?
| | Accidental Falls | 1 | 2024 | 169 | 0.050 |
Why?
| | Early Ambulation | 1 | 2021 | 16 | 0.050 |
Why?
| | Preliminary Data | 1 | 2021 | 9 | 0.050 |
Why?
| | Hospitals, Veterans | 1 | 2021 | 243 | 0.040 |
Why?
| | Health Plan Implementation | 1 | 2021 | 137 | 0.040 |
Why?
| | Databases, Factual | 2 | 2015 | 1269 | 0.040 |
Why?
| | Remission Induction | 1 | 2019 | 274 | 0.040 |
Why?
| | Sphincterotomy, Endoscopic | 1 | 2017 | 27 | 0.040 |
Why?
| | Cholangitis | 1 | 2017 | 20 | 0.040 |
Why?
| | Gallstones | 1 | 2017 | 31 | 0.040 |
Why?
| | Caregivers | 1 | 2024 | 806 | 0.030 |
Why?
| | Pancreatitis | 1 | 2017 | 129 | 0.030 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2017 | 122 | 0.030 |
Why?
| | Program Evaluation | 1 | 2021 | 875 | 0.030 |
Why?
| | Colorado | 2 | 2017 | 4404 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 920 | 0.030 |
Why?
| | Simulation Training | 1 | 2016 | 82 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 271 | 0.030 |
Why?
| | Risk | 1 | 2016 | 855 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 205 | 0.030 |
Why?
| | Organoplatinum Compounds | 1 | 2013 | 41 | 0.030 |
Why?
| | Leucovorin | 1 | 2013 | 70 | 0.030 |
Why?
| | Neck Dissection | 1 | 2012 | 16 | 0.030 |
Why?
| | Camptothecin | 1 | 2013 | 110 | 0.020 |
Why?
| | Pain, Postoperative | 1 | 2014 | 235 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3262 | 0.020 |
Why?
| | Fluorouracil | 1 | 2013 | 197 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2013 | 320 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3152 | 0.020 |
Why?
| | Bariatric Surgery | 1 | 2015 | 196 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1947 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 379 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 819 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1203 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1499 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 611 | 0.020 |
Why?
| | Logistic Models | 1 | 2012 | 1986 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2012 | 3378 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4078 | 0.010 |
Why?
| | Cohort Studies | 1 | 2015 | 5426 | 0.010 |
Why?
| | Child | 1 | 2017 | 20884 | 0.010 |
Why?
|
|
Jones's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|